Autodesk, Inc. (ADSK) Stock

TechnologySoftware - Application Website

ADSK has an Alpha Score of 52 out of 100 (weak), computed on Oct 29, 2026 from 3 of 4 sub-scores. 10 members of Congress disclosed 33 trades in ADSK since 2015: 14 purchases and 19 sales, most recently Alan Armstrong (purchase, Mar 27, 2026). 7 of the hedge funds AlphaScala tracks reported ADSK in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Renaissance Technologies's at $92.91M. Its trailing P/E ratio is 32.8 and its net margin 21.1% (key statistics as of Nov 4, 2026).

$252.32
-2.17%
Last price
Source: Finnhub
Alpha Score
52
Weak

What is ADSK's Alpha Score?

How it works →

Alpha Score of 52 reflects moderate overall profile with moderate momentum, weak value, strong quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.

Momentum
56
Moderate
Value
36
Weak
Quality
82
Strong

Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.

Computed Oct 29, 2026

A rules-based research rating, not a recommendation to buy or sell.

Which members of Congress traded Autodesk, Inc. (ADSK)?

Members
10
Disclosed trades
33
Purchases
14
Sales
19

Most recent: Alan Armstrong (purchase, Mar 27, 2026); records start May 27, 2015.

PoliticianTrade dateTypeAmount
Alan Armstrong
R-OK · Senate
2026-03-27purchase$1k – $15k
Angus King
I-ME · Senate
2026-02-13sale$1k – $15k
Angus King
I-ME · Senate
2025-07-21purchase$1k – $15k
Lisa McClain
R-MI · House
2025-07-10sale$1k – $15k
Lisa McClain
R-MI · House
2025-06-17purchase$1k – $15k
Jefferson Shreve
R-IN · House
2025-05-12sale$15k – $50k
Jefferson Shreve
R-IN · House
2025-04-17purchase$15k – $50k
Byron Donalds
R-FL · House
2025-03-20purchase$1k – $15k

From STOCK Act periodic transaction reports. House filings as of Nov 2, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.

See all ADSK political trades →

Which hedge funds own ADSK?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
Renaissance Technologies
Jim Simons (founder)
478K$92.91M+67%
Marshall Wace236K$45.84M-4%
Citadel
Ken Griffin
142K$27.55M-85%
Bridgewater Associates
Ray Dalio
44K$8.59MNEW
Millennium Management
Israel Englander
28K$5.37M-94%
D.E. Shaw
David Shaw
26K$5.02M-94%
ARK Invest
Cathie Wood
12K$2.38M-2%

13F holdings as of Jun 30, 2026

Explore all tracked funds →

What are ADSK's key statistics?

P/E Ratio
32.83
EPS (TTM)
7.71
Beta
-0.18
Net Margin
21.08%
ROE
52.50%
Debt / Equity
0.82
52W High
$320.00
52W Low
$185.50

Key statistics as of Nov 4, 2026

How does ADSK's valuation compare with the Technology sector?

MetricADSKTechnology medianCompanies in median
P/E ratio32.833.1170
Net margin21.08%12.02%194
Return on equity52.50%15.07%197

Medians over the Technology stocks whose key statistics were refreshed in the last 35 days (newest Nov 4, 2026). P/E excludes loss-making companies.

ADSK price chart

Powered by TradingView

What does Autodesk, Inc. do?

Autodesk, Inc. is a leading provider of design and creation software for professionals across architecture, engineering, construction, manufacturing, and media and entertainment industries. The company develops cloud-based and desktop applications that enable users to design, visualize, and simulate products before manufacturing. Its portfolio includes flagship products for 2D and 3D design, building information modeling, product lifecycle management, and digital content creation. Autodesk serves millions of customers worldwide, from individual designers and small studios to large enterprises and government agencies. The company operates through a subscription-based business model, offering both individual licenses and enterprise solutions. Founded in 1982 and headquartered in San Francisco, California, Autodesk continues to be a dominant force in the design software market, supporting innovation across multiple sectors globally.

CEO
Dr. Andrew Anagnost Ph.D.
Employees
14,300
Market Cap
$53.90B
Ask about ADSKAI research agent